Effect of SARS-CoV-2 BNT162b2 mRNA vaccine on thyroid autoimmunity: A twelve-month follow-up study
An Erratum on
Effect of SARS-CoV-2 BNT162b2 mRNA vaccine on thyroid autoimmunity: a twelve-month follow-up study
by Morita S, Takagi T, Inaba H, Furukawa Y, Kishimoto S, Uraki S, Shimo N, Takeshima K, Uraki S, Doi K, Imagawa M, Kokawa M, Konami T, Hara H, Hara Y, Sone E, Furuta H, Nishi M, Doi A, Tamura S and Matsuoka T-a (2023) Front. Endocrinol. 14:1058007. doi: 10.3389/fendo.2023.1058007
Due to a production error, an author’s name was incorrectly spelled as “Taka-aki Mastuoka”. The correct spelling is “Taka-aki Matsuoka”. The publisher apologizes for this mistake.
The original version of this article has been updated.
Keywords: SARS-CoV-2, COVID-19, thyroid autoimmunity, BNT162b2 vaccine, thyroid-stimulating hormone receptor antibody, Graves’ disease
Citation: Frontiers Production Office (2023) Erratum: Effect of SARS-CoV-2 BNT162b2 mRNA vaccine on thyroid autoimmunity: a twelve-month follow-up study. Front. Endocrinol. 14:1257424. doi: 10.3389/fendo.2023.1257424
Received: 12 July 2023; Accepted: 12 July 2023;
Published: 24 July 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Production Office, cHJvZHVjdGlvbi5vZmZpY2VAZnJvbnRpZXJzaW4ub3Jn